Marc Gelberg

Mr. Gelberg is the Corporate Controller for ADMA Biologics. Mr. Gelberg is responsible for the financial reporting and accounting operations of ADMA, including preparation of the Company’s consolidated financial statements, SEC reporting, financial planning, and maintaining internal control over financial reporting under the Sarbanes-Oxley Act of 2002.